| 136. Antinociceptive activity of botulinum toxin type A in the rat trigeminal region I Matak, B Filipović, V Drinovac, L Bach-Rojecky, Z Lacković Toxicon 93, S42-S42, 2015 | | 2015 |
| 3.310 THE PUZZLE OF BOTULINUM TOXIN AND PAIN Z Lackovic, I Matak, L Bach-Rojecky, B Filipovic, Z Gagula, N Durovic, ... Parkinsonism and Related Disorders, S221, 2012 | | 2012 |
| 6. Botulinum Toxin A in Experimental Migraine Z Lacković, B Filipović, I Matak Acta clinica Croatica 49 (Supplement 2), 87-88, 2010 | | 2010 |
| A hacked kitchen scale-based system for quantification of grip strength in rodents J Homolak, D Virag, I Kodvanj, I Matak, AB Perhoc, A Knezovic, JO Barilar, ... Computers in biology and medicine 144, 105391, 2022 | 7 | 2022 |
| Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches Z Lacković, B Filipović, I Matak, Z Helyes British journal of pharmacology 173 (2), 279-291, 2016 | 72 | 2016 |
| Antigen-Binding Fragments From Purified Human Monoclonal Antibodies Open to the Intrathecal Therapy of Tetanus F Fabris, P Šoštarić, P Meglić, T Marika, G Alessandro, C Davide, ... Toxins 2022 6th International Conference, s61-s62, 2022 | | 2022 |
| Antinociceptive actions of Botulinum toxin A1 on immunogenic hypersensitivity in temporomandibular joint of rats VRM Muñoz-Lora, A Dugonjić Okroša, I Matak, AA Del Bel Cury, ... Toxins 14 (3), 161, 2022 | 8 | 2022 |
| Article Fabris et al. 2023 JCI Insight-UZSM contribution I Matak, P Meglić, P Šoštarić Medicinski fakultet Sveučilišta u Zagrebu, 2024 | | 2024 |
| Article Šoštarić et al. 2022 International Journal of Molecular Sciences I Matak, P Šoštarić Medicinski fakultet, 2024 | | 2024 |
| Article Šoštarić et al. 2024 European Journal of Pharmacology I Matak, P Šoštarić Medicinski fakultet, 2024 | | 2024 |
| Association of intranasal and neurogenic dural inflammation in experimental acute rhinosinusitis L Lovrenčić, I Matak, Z Lacković Frontiers in pharmacology 11, 586037, 2020 | 9 | 2020 |
| ATYPICAL ANALGESIC PROFILE OF BOTULINUM TOXIN TYPE-A: PP63 Z Gagula, L Bach-Rojecky, I Matak, N Djurovic, Z Lackovic Pain Practice 12, 2012 | | 2012 |
| Axonal transport of botulinum toxin A from periphery to CNS in sensory and motor nerves I Matak, L Bach-Rojecky, B Filipović, P Riederer, Z Lacković BMC Pharmacology and Toxicology 13 (Suppl 1), A84, 2012 | 1 | 2012 |
| Basic science of pain and botulinum toxin Z Lacković, I Matak, L Bach-Rojecky Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine …, 2020 | 3 | 2020 |
| Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A I Matak, L Bach-Rojecky, B Filipović, Z Lacković Neuroscience 186, 201-207, 2011 | 222 | 2011 |
| Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement P Šoštarić, M Matić, D Nemanić, ŽL Vasić, M Cifrek, M Pirazzini, I Matak European journal of pharmacology 962, 176242, 2024 | 2 | 2024 |
| Botulinum Neurotoxin Type A Antinociceptive Activity in Spinal Cord and Trigeminal Sensory Nociceptive Nuclei Involves Central Trans-Synaptic Transport D Nemanić, L Bach-Rojecky, I Matak Toxicon 237, 107463, 2024 | | 2024 |
| Botulinum Neurotoxin Type A Regulates Spinal Premotor Inputs Participating in Normal Locomotion and Experimental Spasticity in Rats I Matak, P Šoštarić Toxicon 237, 107453, 2024 | | 2024 |
| Botulinum neurotoxin type A: actions beyond SNAP-25? I Matak, Z Lacković Toxicology 335, 79-84, 2015 | 61 | 2015 |
| Botulinum toxin A in a rat model of migraine and/or trigeminal neuropathy B Filipović, I Matak, L Bach-Rojecky, Z Lacković Hrvatski farmakološki kongres s međunarodnim sudjelovanjem (6; 2010), 88-88, 2010 | | 2010 |
Zdravko LackovicProfesor farmakologije, Sveučilište u Zagrebu Medicinski fakultet在 mef.hr 的电子邮件经过验证
